Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

被引：0

作者：

Piero Barbanti

Gabriella Egeo

Cinzia Aurilia

Florindo d’Onofrio

Maria Albanese

Ilaria Cetta

Paola Di Fiore

Maurizio Zucco

Massimo Filippi

Francesco Bono

Claudia Altamura

Stefania Proietti

Stefano Bonassi

Fabrizio Vernieri

机构：

[1] Headache and Pain Unit,Neurology Unit

[2] IRCCS San Rafaele Pisana,Regional Referral Headache CenterNeurology Unit

[3] San Rafaele University,Department of Systems Medicine

[4] San Giuseppe Moscati Hospital,Headache Unit, Department of Neurology

[5] University Hospital Tor Vergata,Headache Center, Neurlogy Unit

[6] University of Rome Tor Vergata,Neurology Unit, IRCCS San Rafaele Scientifc Institute

[7] Scientifc Institute San Rafaele Hospital,Headache and Neurosonology Unit

[8] Vita-Salute University,Department of Human Sciences and Quality of Life Promotion

[9] Headache Center,Headache and Neurosonology Unit

[10] ASST Santi Paolo Carlo,undefined

[11] San Camillo-Forlanini Hospital,undefined

[12] Vita-Salute San Raffaele University,undefined

[13] Center for Headache and Intracranial Pressure Disorders,undefined

[14] Neurology Unit,undefined

[15] A.O.U. Mater Domini,undefined

[16] Policlinico Universitario Campus Bio-Medico,undefined

[17] Clinical and Molecular Epidemiology,undefined

[18] IRCCS San Rafaele,undefined

[19] San Rafaele University,undefined

[20] Campus BioMedico University Hospital,undefined

来源：

The Journal of Headache and Pain | 2022年 / 23卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] European multicenter study on the use of anti-CGRP monoclonal antibodies in real life for migraine prevention: study cohort description
Caronna, Edoardo
Jose Gallardo, Victor
Alpuente, Alicia
Torres-Ferrus, Marta
Huerta Villanueva, Mariano
Munoz, Albert
Campoy, Sergio
Cuadrado Godia, Elisa
Dorado, Laura
Obach, Victor
Fabregat, Neus
Rodriguez Vico, Jaime
Diaz de Teran, Javier
Membrilla, Javier
Pascual, Julio
Garate, Gabriel
Gago, Ana
Guerrero, Angel
Sanahuja, Jordi
Sanchez Soblechero, Antonio
Lozano Ros, Alberto
Irimia Sieira, Pablo
Sanchez del Rio, Margarita
Echeverria Urabayen, Amaya
Garcia Azorin, David
Gonzalez Osorio, Yesica
Gonzalez Quintanilla, Vicente
Lopez Bravo, Alba
Fernandez Lazaro, Iris
Quintas Gutierrez, Sonia
Gonzalez-Martinez, Alicia
Flores Pina, Belen
Manera Zorrilla-Lequerica, Paula
Jaimes Sanchez, Alex
Garcia Gomez, Andrea
Alvarez Escudero, Rocio
Oterino Duran, Agustin
Velasco Juanes, Fernando
Sifontes, Walter
Rodriguez Montolio, Joana
Nieves Castellanos, Candela
Olivier, Marina
Layos-Romero, Almudena
Andres Lopez, Alberto
Sanchez Caballero, Francisco
Beltran Blasco, Isabel
Millan Vazquez, Manuel
Lamas Perez, Raquel
Viguera Romero, Javier
Santos-Lasaosa, Sonia
CEPHALALGIA, 2023, 43 (1supp)
[42] Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study
Vernieri, Fabrizio
Altamura, Claudia
Brunelli, Nicoletta
Costa, Carmelina Maria
Aurilia, Cinzia
Egeo, Gabriella
Fofi, Luisa
Favoni, Valentina
Lovati, Carlo
Bertuzzo, Davide
D'Onofrio, Florindo
Doretti, Alberto
Di Fiore, Paola
Finocchi, Cinzia
Di Cola, Francesca Schiano
Ranieri, Angelo
Colombo, Bruno
Bono, Francesco
Albanese, Maria
Cevoli, Sabina
Barbanti, Piero
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (04) : 1198 - 1208
[43] Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients
Raffaele Ornello
Fayyaz Ahmed
Andrea Negro
Anna Maria Miscio
Antonio Santoro
Alicia Alpuente
Antonio Russo
Marcello Silvestro
Sabina Cevoli
Nicoletta Brunelli
Fabrizio Vernieri
Licia Grazzi
Carlo Baraldi
Simona Guerzoni
Anna P. Andreou
Giorgio Lambru
Katharina Kamm
Ruth Ruscheweyh
Marco Russo
Paola Torelli
Elena Filatova
Nina Latysheva
Anna Gryglas-Dworak
Marcin Straburzyński
Calogera Butera
Bruno Colombo
Massimo Filippi
Patricia Pozo-Rosich
Paolo Martelletti
Simona Sacco
Pain and Therapy, 2021, 10 : 1605 - 1618
[44] Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients
Ornello, Raffaele
Ahmed, Fayyaz
Negro, Andrea
Miscio, Anna Maria
Santoro, Antonio
Alpuente, Alicia
Russo, Antonio
Silvestro, Marcello
Cevoli, Sabina
Brunelli, Nicoletta
Vernieri, Fabrizio
Grazzi, Licia
Baraldi, Carlo
Guerzoni, Simona
Andreou, Anna P.
Lambru, Giorgio
Kamm, Katharina
Ruscheweyh, Ruth
Russo, Marco
Torelli, Paola
Filatova, Elena
Latysheva, Nina
Gryglas-Dworak, Anna
Straburzynski, Marcin
Butera, Calogera
Colombo, Bruno
Filippi, Massimo
Pozo-Rosich, Patricia
Martelletti, Paolo
Sacco, Simona
PAIN AND THERAPY, 2021, 10 (02) : 1605 - 1618
[45] Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Mingot, Cristina Gonzalez
Lasaosa, Sonia Santos
Campas, Laura Colas
Canaval, Laura Chilangua
Sanchez, Anna Gil
Ruiz, Luis Brieva
Alonso, Maria Cristina Marzo
Moncusi, Silvia Peralta
Marsal, Joan Valls
Carner, Serafi Cambray
Garcia, Francisco Purroy
SCIENTIFIC REPORTS, 2023, 13 (01)
[46] Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Cristina González Mingot
Sonia Santos Lasaosa
Laura Colàs Campàs
Laura Chilangua Canaval
Anna Gil Sánchez
Luis Brieva Ruiz
María Cristina Marzo Alonso
Silvia Peralta Moncusi
Joan Valls Marsal
Serafí Cambray Carner
Francisco Purroy García
Scientific Reports, 13
[47] Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience
Altamura, Claudia
Brunelli, Nicoletta
Marcosano, Marilena
Aurilia, Cinzia
Egeo, Gabriella
Lovati, Carlo
Favoni, Valentina
Perrotta, Armando
Maestrini, Ilaria
Di Cola, Francesca Schiano
d'Onofrio, Florindo
Finocchi, Cinzia
Bertuzzo, Davide
Bono, Francesco
Ranieri, Angelo
Albanese, Maria
Messina, Roberta
Doretti, Alberto
Di Piero, Vittorio
Cevoli, Sabina
Barbanti, Piero
Vernieri, Fabrizio
JOURNAL OF NEUROLOGY, 2022, 269 (11) : 5848 - 5857
[48] Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience
Claudia Altamura
Nicoletta Brunelli
Marilena Marcosano
Cinzia Aurilia
Gabriella Egeo
Carlo Lovati
Valentina Favoni
Armando Perrotta
Ilaria Maestrini
Francesca Schiano Di Cola
Florindo d’Onofrio
Cinzia Finocchi
Davide Bertuzzo
Francesco Bono
Angelo Ranieri
Maria Albanese
Roberta Messina
Alberto Doretti
Vittorio Di Piero
Sabina Cevoli
Piero Barbanti
Fabrizio Vernieri
Journal of Neurology, 2022, 269 : 5848 - 5857
[49] REAL-LIFE USE OF ONABOTULINUMTOXINA FOR THE SYMPTOMATIC TREATMENT OF CHRONIC MIGRAINE: 12-MONTH REPOSE STUDY INTERIM ANALYSIS
Pascual, J.
Gaul, C.
Davies, B.
Brown, S.
Ahmed, F.
CEPHALALGIA, 2016, 36 : 39 - 40
[50] Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study (Vol 13, Pg 611, 2024)
Barbanti, Piero
Egeo, Gabriella
Proietti, Stefania
d'Onofrio, Florindo
Aurilia, Cinzia
Finocchi, Cinzia
Di Clemente, Laura
Zucco, Maurizio
Doretti, Alberto
Messina, Stefano
Autunno, Massimo
Ranieri, Angelo
Carnevale, Antonio
Colombo, Bruno
Filippi, Massimo
Tasillo, Miriam
Rinalduzzi, Steno
Querzani, Pietro
Sette, Giuliano
Forino, Lorenzo
Zoroddu, Francesco
Robotti, Micaela
Valenza, Alessandro
Camarda, Cecilia
Borrello, Laura
Aguggia, Marco
Viticchi, Giovanna
Tomino, Carlo
Fiorentini, Giulia
Orlando, Bianca
Bonassi, Stefano
Torelli, Paola
NEUROLOGY AND THERAPY, 2024, 13 (05) : 1505 - 1506

← 1 2 3 4 5 →